Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)
Clinical trial NCT04021108 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04021108
- Sponsor
- Weill Medical College of Cornell University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-22
- Primary completion
- 2025-06-11
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.